| |
| |
|
| Insider
Information: |
Fairman Jeff |
| Relationship: |
VP, Research |
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
17,143 |
|
|
Indirect Shares
|
346,227 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
363,370 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vaxcyte, Inc. |
PCVX |
VP, Research |
2022-10-11 |
17,143 |
2022-10-11 |
346,227 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PCVX |
Vaxcyte, Inc. |
VP, Research |
• – – |
2022-10-11 |
4 |
AS |
$25.50 |
$127,500 |
I/I |
(5,000) |
296,227 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
VP, Research |
• – – |
2022-09-06 |
4 |
AS |
$26.54 |
$132,892 |
I/I |
(5,000) |
301,227 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
VP, Research |
• – – |
2022-09-02 |
4 |
D |
$26.38 |
$13,691 |
D/D |
(519) |
17,143 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
VP, Research |
• – – |
2022-08-05 |
4 |
AS |
$25.70 |
$128,508 |
I/I |
(5,000) |
306,227 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
VP, Research |
• – – |
2022-08-04 |
4 |
AS |
$25.50 |
$255,000 |
I/I |
(10,000) |
311,227 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
VP, Research |
• – – |
2022-05-20 |
4 |
AS |
$25.50 |
$104,856 |
I/I |
(4,112) |
321,227 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
VP, Research |
• – – |
2022-05-05 |
4 |
AS |
$25.80 |
$22,914 |
I/I |
(888) |
325,339 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
VP, Research |
• – – |
2022-04-05 |
4 |
AS |
$25.59 |
$127,950 |
I/I |
(5,000) |
326,227 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
VP, Research |
• – – |
2022-03-11 |
4 |
AS |
$25.50 |
$255,000 |
I/I |
(10,000) |
331,227 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
VP, Research |
• – – |
2022-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
16,629 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
VP, Research |
• – – |
2021-12-27 |
4 |
AS |
$23.58 |
$112,093 |
D/D |
(4,750) |
6,160 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
VP, Research |
• – – |
2021-12-27 |
4 |
OE |
$1.79 |
$8,503 |
D/D |
4,750 |
10,910 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
VP, Research |
• – – |
2021-12-20 |
4 |
OE |
$1.79 |
$8,000 |
D/D |
4,469 |
10,629 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
VP, Research |
• – – |
2021-12-16 |
4 |
AS |
$22.50 |
$103,928 |
D/D |
(4,619) |
6,160 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
VP, Research |
• – – |
2021-12-16 |
4 |
OE |
$1.79 |
$8,268 |
D/D |
4,619 |
10,779 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
VP, Research |
• – – |
2021-12-09 |
4 |
AS |
$22.50 |
$2,948 |
D/D |
(131) |
6,160 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
VP, Research |
• – – |
2021-12-09 |
4 |
OE |
$1.79 |
$234 |
D/D |
131 |
6,291 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
VP, Research |
• – – |
2021-10-26 |
4 |
AS |
$22.69 |
$107,778 |
D/D |
(4,750) |
5,144 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
VP, Research |
• – – |
2021-10-26 |
4 |
OE |
$1.79 |
$8,503 |
D/D |
4,750 |
9,894 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
VP, Research |
• – – |
2021-09-27 |
4 |
AS |
$26.16 |
$124,303 |
D/D |
(4,750) |
5,144 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
VP, Research |
• – – |
2021-09-27 |
4 |
OE |
$1.79 |
$8,503 |
D/D |
4,750 |
9,894 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
VP, Research |
• – – |
2021-08-26 |
4 |
AS |
$24.70 |
$120,543 |
D/D |
(4,750) |
5,144 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
VP, Research |
• – – |
2021-08-26 |
4 |
OE |
$1.79 |
$8,503 |
D/D |
4,750 |
9,894 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
VP, Research |
• – – |
2021-07-26 |
4 |
AS |
$22.70 |
$107,825 |
D/D |
(4,750) |
5,144 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
VP, Research |
• – – |
2021-07-26 |
4 |
OE |
$1.79 |
$8,503 |
D/D |
4,750 |
9,894 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
